Nanobodies can well replace conventional antibodies in immunoassay for the detection of small molecular weight compounds. A nanobody-based ELISA for OTA with high resistance to matrix interference was developed. A possible approach to produce antibodies with improved specificity was proposed. The binding kinetics of nanobodies to ochratoxin A was tested with a bio-layer interferometry-based BLItz system.